# A Study of ASN007 in Patients With Advanced Solid Tumors

> **NCT03415126** · PHASE1 · COMPLETED · sponsor: **Asana BioSciences** · enrollment: 49 (actual)

## Conditions studied

- Cancer
- Malignancy
- Neoplasia
- Neoplasm
- Neoplasm Metastasis
- Colon Cancer
- Colonic Neoplasms
- Colon Cancer Liver Metastasis
- Metastatic Cancer
- Metastatic Melanoma
- Metastatic Colon Cancer
- Metastatic Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- Pancreatic Cancer
- Pancreas Cancer
- Pancreas Adenocarcinoma
- Pancreas Neoplasm
- Metastatic Nonsmall Cell Lung Cancer
- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** ASN007: ascending doses
- **DRUG:** ASN007 RD

## Key facts

- **NCT ID:** NCT03415126
- **Lead sponsor:** Asana BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-19
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2020-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415126, "A Study of ASN007 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03415126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*